a) prostate specific antigen (PSA) is specific to the prostate but not to prostate cancer b) PSA cannot discriminate different cancer stages c) The introduction of PSA as a screening test has led to substantial 'overdiagnosis' d) PSA screening does not affect prostate cancer mortality
Friday, 28 March 2008 - Dr. Claus Nolte-Ernsting discussed the emergence of magnetic resonance urography (MRU) as a diagnostic tool that offers benefits particularly for the imaging of the upper urinary tract at the EAU-ESUR...
Filed by: Joel Vega